Back

Newly emerging data from the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial: an investigator’s perspective.

28 August 2016 (13:00 - 13:10)
Organised by:
Congress Presentation Part of: Clinical considerations for cardiologists: exploring the evidence for primary and secondary prevention in type 2 diabetes Diabetes management ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Paul Wayne Armstrong

University of Alberta, Edmonton (Canada)

6 More presentations in this session

Presentation thumbnail
Welcome and introduction - Clinical considerations for cardiologists: exploring the evidence for primary and secondary prevention in type 2 diabetes.
Professor G. De Ferrari (Turin, IT) Professor L. Leiter (Toronto, CA)
Presentation thumbnail
Coprevalence of comorbidities and their role in the choices of treatment for the diabetic patient with cardiovascular disease.
Professor N. Marx (Aachen, DE)
Presentation thumbnail
Diabetes cardiovascular safety trials: an endocrinologist’s interpretation of emergent data.
Professor L. Leiter (Toronto, CA)
Presentation thumbnail
Closing the gap: the EUROASPIRE study (European Action on Secondary Prevention by Intervention to Reduce Events) and what it can tell us for the treatment of diabetes patients.
Professor L. Ryden (Stockholm, SE)
Presentation thumbnail
Q&A - Clinical considerations for cardiologists: exploring the evidence for primary and secondary prevention in type 2 diabetes.
Professor L. Leiter (Toronto, CA) Professor N. Marx (Aachen, DE) Professor L. Ryden (Stockholm, SE) Doctor P. Armstrong (Edmonton, CA)

Access the full session

Session thumbnail
Clinical considerations for cardiologists: exploring the evidence for primary and secondary prevention in type 2 diabetes

The Event

Event poster

ESC Congress 2016

28 August 2016 13:00 CET
You may be interested in
thumbnail
Congress Session
A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future
27 August 2023
thumbnail
Congress Presentation
Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
27 August 2021
thumbnail
Congress Presentation
Absolute treatment effects of novel oral antidiabetic drugs on cardiovascular mortality and hospitalization for heart failure: a meta-analysis of digitalized individual patient outcomes
27 August 2022
thumbnail
Congress Presentation
Comparison of cardiovascular outcomes in patients with diabetes treated with tirzepatide versus semaglutide: a multi-institutional analysis
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources